1. Abolghasemi, M, Tehrani, SS, Yousefi, T, et al. (2020) MicroRNAs in breast cancer: Roles, functions, and mechanism of actions. Journal of Cellular Physiology 235: 5008–5029.
Google Scholar | Crossref | Medline2. Abolghasemi, M, Tehrani, SS, Yousefi, T, et al. (2020) Critical roles of long noncoding RNAs in breast cancer. Journal of Cellular Physiology 235: 5059–5071.
Google Scholar | Crossref | Medline3. Fan, L, Strasser-Weippl, K, Li, J-J, et al. (2014) Breast cancer in China. The Lancet Oncology 15(7): e279–e289.
Google Scholar | Crossref | Medline4. Sun, Y-S, Zhao, Z, Yang, Z-N, et al. (2017) Risk factors and preventions of breast cancer. International Journal of Biological Sciences 13(11): 1387–1397.
Google Scholar | Crossref | Medline5. Yuan, Y (2011) Study on the Extraction and Analysis of Podophyllotoxin and the New Method of Quality Control[D]. Changsha, China: Hunan University.
Google Scholar6. Lu, J (2009) The pharmacology and clinical application of Dysosma Versipellis[J]. Modern Medicine and Health (23): 3608–3609.
Google Scholar7. Mukherjee, A, Basu, S, Sarkar, N, et al. (2001) Advances in cancer therapy with plant based natural products. Current Medicinal Chemistry 8: 1467–1486.
Google Scholar | Crossref | Medline8. Mantle, D, Lennard, TW, Pickering, AT (2000) Therapeutic applications of medicinal plants in the treatment of breast cancer: a review of their pharmacology, efficacy and tolerability. Adverse drug reactions and toxicological reviews 19: 223–240.
Google Scholar | Medline9. Ezzati, M, Yousefi, B, Velaei, K, et al. (2020) A review on anti-cancer properties of Quercetin in breast cancer. Life Sciences 248: 117463.
Google Scholar | Crossref | Medline10. Kasiri, N, Rahmati, M, Ahmadi, L, et al. (2020) Therapeutic potential of Quercetin on human breast cancer in different dimensions. Inflammopharmacology 28(1): 39–62.
Google Scholar | Crossref | Medline11. Zhu, L, Xue, L (2019) Kaempferol suppresses proliferation and induces cell cycle arrest, apoptosis, and DNA damage in breast cancer cells. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 27(6): 629–634.
Google Scholar | Crossref12. Awad, AB, Roy, R, Fink, CS (2003) Beta-sitosterol, a plant sterol, induces apoptosis and activates key caspases in MDA-MB-231 human breast cancer cells. Oncology reports 10(2): 497–500.
Google Scholar | Medline13. Awad, AB, Barta, SL, Fink, CS, et al. (2008) β-Sitosterol enhances tamoxifen effectiveness on breast cancer cells by affecting ceramide metabolism. Molecular Nutrition & Food Research 52(4): 419–426.
Google Scholar | Crossref | Medline14. Chua, LS A review on plant-based rutin extraction methods and its pharmacological activities. Journal of Ethnopharmacology. 2013;150(3):805-817.
Google Scholar | Crossref | Medline15. Dogra, A, Gour, A, Bhatt, S, et al. (2013) A review on plant-based rutin extraction methods and its pharmacological activities. Journal of Ethnopharmacology 150(3): 805–817.
Google Scholar | Crossref | Medline16. Elsayed, HE, Ebrahim, HY, Mohyeldin, MM, et al. (2017) Rutin as a novel c-met inhibitory lead for the control of triple negative breast malignancies. Nutrition and Cancer 69(8): 1256–1271.
Google Scholar | Crossref | Medline17. Novak, CM, Horst, EN, Taylor, CC, et al. (2019) Fluid shear stress stimulates breast cancer cells to display invasive and chemoresistant phenotypes while upregulating PLAU in a 3D bioreactor. Biotechnology and Bioengineering 116(11): 3084–3097.
Google Scholar | Crossref | Medline18. Wu, M-Y, Li, C-J, Hou, M-F, et al. (2017) New insights into the role of inflammation in the pathogenesis of atherosclerosis. International Journal of Molecular Sciences 18(10): 2034.
Google Scholar | Crossref19. Zhou, S, Jin, J, Wang, J, et al. (2021) Effects of breast cancer genes 1 and 2 on cardiovascular diseases. Current Problems in Cardiology 46(3): 100421.
Google Scholar | Crossref | Medline20. Sepahvand, P, Makvandi, M, Samarbafzadeh, A, et al. (2019) Human Cytomegalovirus DNA among Women with Breast Cancer. Asian Pacific Journal of Cancer Prevention 20(8): 2275–2279.
Google Scholar | Crossref | Medline21. Goodrum, F, Caviness, K, Zagallo, P (2012) Human cytomegalovirus persistence. Cellular Microbiology 14(5): 644–655.
Google Scholar | Crossref | Medline22. Gong, Y, Zhao, J, Wang, M (2016) Research progress on the relationship between human cytomegalovirus infection and breast cancer[J]. Microbes and Infection 11(01): 55–58.
Google Scholar23. Liu, Z, Jiang, L, Liang, G, et al. (2017) Hepatitis B virus reactivation in breast cancer patients undergoing chemotherapy: a review and meta-analysis of prophylaxis management. Journal of Viral Hepatitis 24(7): 561–572.
Google Scholar | Crossref | Medline24. Wu, H, Zhao, C, Adhikari, VP, et al. (2017) The prevalence and clinicopathological features of breast cancer patients with hepatitis B virus infection in China. Oncotarget 8(11): 18185–18190.
Google Scholar | Crossref | Medline25. Hu, N, Zhang, J, Cui, W, et al. (2011) miR-520b regulates migration of breast cancer cells by targeting hepatitis B X-interacting protein and interleukin-8. Journal of Biological Chemistry 286(15): 13714–13722.
Google Scholar | Crossref | Medline26. Ellis, H, Ma, CX (2019) PI3K inhibitors in breast cancer therapy. Current Oncology Reports 21(12): 110.
Google Scholar | Crossref | Medline27. Rahmani, F, Ferns, GA, Talebian, S, et al. (2020) Role of regulatory miRNAs of the PI3K/AKT signaling pathway in the pathogenesis of breast cancer. Gene 737: 144459.
Google Scholar | Crossref | Medline28. Lourenco, C, Kalkat, M, Houlahan, KE, et al. (2019) Modelling the MYC-driven normal-to-tumour switch in breast cancer. Disease models & mechanisms 12(7): dmm038083.
Google Scholar | Crossref | Medline29. Liang, Z-R, Qu, L-H, Ma, L-M (2020) Differential impacts of charcoal-stripped fetal bovine serum on c-Myc among distinct subtypes of breast cancer cell lines. Biochemical and Biophysical Research Communications 526(1): 267–272.
Google Scholar | Crossref | Medline30. Tokunaga, R, Zhang, W, Naseem, M, et al. (2018) CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - a target for novel cancer therapy. Cancer Treatment Reviews 63: 40–47.
Google Scholar | Crossref | Medline31. Liu, L, Callahan, MK, Huang, D, et al. (2005) Chemokine receptor CXCR3: an unexpected enigma. Current Topics in Developmental Biology 68: 149–181.
Google Scholar | Crossref | Medline32. Ertosun, MG, Hapil, FZ, Osman Nidai, O (2016) E2F1 transcription factor and its impact on growth factor and cytokine signaling. Cytokine & Growth Factor Reviews 31: 17–25.
Google Scholar | Crossref | Medline33. Zheng, X, Huang, M, Xing, L, et al. (2020) The circRNA circSEPT9 mediated by E2F1 and EIF4A3 facilitates the carcinogenesis and development of triple-negative breast cancer. Molecular Cancer 19(1): 73.
Google Scholar | Crossref | Medline